News
As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, ...
1d
Stockhead on MSNLTR Pharma completes study milestone for SPONTAN ED treatmentLTR Pharma has completed a key extractables study for its SPONTAN intranasal spray for erectile dysfunction and kicked off a ...
MONTREAL and CHARLOTTE, N.C., June 16, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced submission of its response to the U.S. Food and Drug Administration ...
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced submission of its response to the U.S. Food and Drug Administration (FDA)’s Complete Response Letter (CRL) regarding its New Drug ...
A new study found that almost all plans in 40 states and Washington, DC covered at least one form of the opioid overdose ...
ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...
Due to the drug's high strength, multiple doses of naloxone could be required to reverse an overdose. The drug's reemergence ...
An alternative to epinephrine autoinjectors that can be delivered by a nasal spray has been launched in Germany, its first ...
The Centers for Disease Control and Prevention's vaccine advisory committee is set to meet for the first time since Health ...
Michigan Department of Health and Human Services officials warned about the reemergence of a potent fentanyl alteration.
Xlear, a company based in American Fork, is suing the FTC, fighting regulations restricting its ability to market hygiene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results